L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma

Clinical trial NCT06478381 · UNKNOWN

Trial details

NCT number: NCT06478381
Sponsor: Henan Cancer Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory B-cell Lymphomas

Start date: 2024-06-01
Primary completion: 2025-12-31
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.